HOOKIPA Pharma Inc.
NASDAQ:HOOK
3.81 (USD) • At close November 5, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 1.29 | 36.599 | 7.407 | 6.867 | 2.679 | 3.176 | 7.828 | 2.23 | 2.746 | 1.445 | 3.895 | 3.874 | 5.378 | 5.301 | 5.163 | 4.04 | 6.685 | 3.696 | 3.618 | 2.038 | 4.051 | 2.235 | 5.08 | 1.9 | 0.649 | 0 |
| Cost of Revenue
| 0.714 | 0.64 | 1.278 | 0.487 | 0.866 | 0.921 | 0.904 | 0.76 | 0.86 | 1.078 | 1.228 | 20.698 | 19.572 | 20.164 | 13.464 | 16.009 | 11.564 | 11.526 | 11.179 | 11.025 | 13.929 | 10.179 | 4.615 | 6.17 | 6.211 | 4.969 |
| Gross Profit
| 0.576 | 35.959 | 6.129 | 6.38 | 1.813 | 2.255 | 6.924 | 1.47 | 1.886 | 0.367 | 2.667 | -16.824 | -14.194 | -14.863 | -8.301 | -11.969 | -4.879 | -7.83 | -7.561 | -8.987 | -9.878 | -7.944 | 0.465 | -4.27 | -5.562 | -4.969 |
| Gross Profit Ratio
| 0.447 | 0.983 | 0.827 | 0.929 | 0.677 | 0.71 | 0.885 | 0.659 | 0.687 | 0.254 | 0.685 | -4.343 | -2.639 | -2.804 | -1.608 | -2.963 | -0.73 | -2.119 | -2.09 | -4.41 | -2.438 | -3.554 | 0.092 | -2.247 | -8.57 | 0 |
| Reseach & Development Expenses
| 19.749 | 20.168 | 21.162 | 24.625 | 19.706 | 20.931 | 17.592 | 18.286 | 16.147 | 16.62 | 22.419 | 20.698 | 19.572 | 20.164 | 15.688 | 16.009 | 11.564 | 11.526 | 11.179 | 11.025 | 13.929 | 10.179 | 4.615 | 6.17 | 6.211 | 4.969 |
| General & Administrative Expenses
| 3.945 | 4.056 | 4.374 | 4.912 | 4.445 | 4.902 | 3.824 | 4.937 | 5.026 | 4.972 | 3.523 | 4.342 | 5.095 | 4.309 | 4.669 | 4.437 | 4.347 | 4.629 | 5.664 | 4.589 | 3.751 | 2.711 | 2.669 | 1.282 | 1.413 | 1.48 |
| Selling & Marketing Expenses
| -0.714 | -0.64 | -1.278 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 3.231 | 3.416 | 3.096 | 4.912 | 4.445 | 4.902 | 3.824 | 4.937 | 5.026 | 4.972 | 3.523 | 4.342 | 5.095 | 4.309 | 4.669 | 4.437 | 4.347 | 4.629 | 5.664 | 4.589 | 3.751 | 2.711 | 2.669 | 1.282 | 1.413 | 1.48 |
| Other Expenses
| -0.218 | -0.285 | 1.342 | -0.833 | 0.025 | -0.22 | -1.285 | -2.081 | -1.958 | -1.887 | -1.495 | -1.133 | -0.158 | -0.058 | 1.457 | 0.994 | 0.646 | -0.024 | -0.091 | 0.604 | -0.195 | 0.283 | 0.114 | 0.033 | -0.036 | 0.022 |
| Operating Expenses
| 22.98 | 23.584 | 24.258 | 29.537 | 21.934 | 25.833 | 21.416 | 21.142 | 19.215 | 19.705 | 25.942 | 22.553 | 22.162 | 22.269 | 20.357 | 18.449 | 14.316 | 14.683 | 16.843 | 14.356 | 16.136 | 11.698 | 6.889 | 5.69 | 6.24 | 4.378 |
| Operating Income
| -22.404 | 12.375 | -18.129 | -22.67 | -21.472 | -22.657 | -13.588 | -20.993 | -18.427 | -20.147 | -22.047 | -21.166 | -19.289 | -19.172 | -15.194 | -16.406 | -9.226 | -12.459 | -13.225 | -13.576 | -13.629 | -10.655 | -2.204 | -5.552 | -6.975 | -6.449 |
| Operating Income Ratio
| -17.367 | 0.338 | -2.448 | -3.301 | -8.015 | -7.134 | -1.736 | -9.414 | -6.71 | -13.943 | -5.66 | -5.464 | -3.587 | -3.617 | -2.943 | -4.061 | -1.38 | -3.371 | -3.655 | -6.661 | -3.364 | -4.767 | -0.434 | -2.922 | -10.747 | 0 |
| Total Other Income Expenses Net
| 3.309 | 2.008 | -6.525 | 3.604 | 0.025 | 2.977 | 1.277 | 2.713 | 2.072 | 2.179 | -1.495 | -1.133 | -0.158 | -0.058 | 1.457 | 0.994 | 0.646 | -0.024 | -0.091 | 0.604 | -0.195 | 0.283 | 0.114 | 0.033 | -0.036 | 0.022 |
| Income Before Tax
| -19.095 | 14.383 | -24.654 | -19.066 | -18.016 | -19.68 | -12.311 | -18.28 | -16.355 | -17.968 | -21.235 | -20.039 | -17.153 | -17.238 | -12.475 | -13.589 | -7.092 | -10.926 | -10.244 | -11.376 | -11.979 | -9.329 | -1.895 | -3.951 | -5.818 | -4.549 |
| Income Before Tax Ratio
| -14.802 | 0.393 | -3.328 | -2.776 | -6.725 | -6.196 | -1.573 | -8.197 | -5.956 | -12.435 | -5.452 | -5.173 | -3.189 | -3.252 | -2.416 | -3.364 | -1.061 | -2.956 | -2.831 | -5.582 | -2.957 | -4.174 | -0.373 | -2.079 | -8.965 | 0 |
| Income Tax Expense
| 0 | 0.597 | 0.164 | -0.487 | 0.122 | 0.205 | 0.229 | -2.713 | 0.001 | -2.179 | -0.002 | 0.001 | 0.06 | 0.161 | -3.889 | 1.188 | 0.812 | 0.203 | -0.109 | 0.009 | 0.1 | 0.496 | -0.003 | 0.002 | 0.001 | 0.024 |
| Net Income
| -19.095 | 14.383 | -24.818 | -19.066 | -18.016 | -19.68 | -12.311 | -18.28 | -16.356 | -17.968 | -21.235 | -20.04 | -17.153 | -17.238 | -12.474 | -13.589 | -7.092 | -10.926 | -10.244 | -11.385 | -12.079 | -9.329 | -1.892 | -3.953 | -5.819 | -4.573 |
| Net Income Ratio
| -14.802 | 0.393 | -3.351 | -2.776 | -6.725 | -6.196 | -1.573 | -8.197 | -5.956 | -12.435 | -5.452 | -5.173 | -3.189 | -3.252 | -2.416 | -3.364 | -1.061 | -2.956 | -2.831 | -5.586 | -2.982 | -4.174 | -0.372 | -2.081 | -8.966 | 0 |
| EPS
| -1.52 | 1.1 | -2.51 | -1.73 | -2.18 | -2.73 | -2.25 | -0.25 | -0.23 | -0.4 | -0.65 | -0.61 | -0.52 | -0.53 | -0.46 | -0.53 | -0.28 | -0.43 | -0.4 | -0.45 | -0.63 | -0.37 | -0.12 | -0.24 | -0.36 | -0.28 |
| EPS Diluted
| -1.52 | 1.1 | -2.51 | -1.73 | -2.18 | -2.73 | -2.25 | -0.25 | -0.23 | -0.4 | -0.65 | -0.61 | -0.52 | -0.53 | -0.46 | -0.53 | -0.28 | -0.43 | -0.4 | -0.45 | -0.63 | -0.37 | -0.12 | -0.24 | -0.36 | -0.28 |
| EBITDA
| -21.69 | 13.015 | -16.851 | -22.67 | -17.053 | -22.657 | -13.588 | -17.415 | -15.264 | -16.647 | -22.047 | -18.714 | -15.717 | -15.916 | -15.194 | -12.759 | -6.448 | -10.29 | -13.225 | -10.383 | -10.93 | -8.55 | -1.517 | -3.586 | -5.476 | -4.216 |
| EBITDA Ratio
| -16.814 | 0.356 | -2.275 | -3.301 | -6.365 | -7.134 | -1.736 | -7.809 | -5.559 | -11.52 | -5.66 | -4.831 | -2.922 | -3.002 | -2.943 | -3.158 | -0.965 | -2.784 | -3.655 | -5.095 | -2.698 | -3.826 | -0.299 | -1.887 | -8.438 | 0 |